Exhibit 99.1

 

 

 

Alto Ingredients Reports Third Quarter 2021 Results

 

Third Quarter Net Loss of $3.5 million and Positive Adjusted EBITDA of $3.0 million

 

Subsequent to Quarter-End, the Company Sold its Stockton, CA Facility

 

Company is Now Term Debt Free

 

Sacramento, CA, November 9, 2021 – Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer of specialty alcohols and essential ingredients, reported its financial results for the third quarter ended September 30, 2021.

 

“In the third quarter we made significant progress in advancing our strategic initiatives, expanding our essential ingredients business and improving our infrastructure,” said Mike Kandris, CEO of Alto Ingredients. “We launched an enhanced protein project through the installation of Harvesting Technology’s patented CoPromax™ system at our Magic Valley, Idaho facility. At our Pekin campus, we made significant progress on a number of initiatives. We completed our yeast expansion project and will have our upgraded feed dryers operational by year end. We also finished expanding the capacity of our corn oil production and significantly improved the efficiency and reliability of our Pekin wet mill to further support customer demand long term. We are also working on extending the certifications we obtained at the end of 2020 from our ICP distillery to our Pekin wet mill. We expect to complete this effort by the end of this year and by doing so, provide unique redundancy across the entire Pekin campus and further surety of quality supply to our customers.

 

“Subsequent to quarter end, on November 8th we announced the sale of our Stockton, California fuel-grade ethanol facility, completing the realignment of our fuel-grade ethanol operations we began 21 months ago. The proceeds from these asset sales were integral to our strategy and contributed to the retirement of approximately $150 million dollars in term debt over this same period – thus achieving our stated goal to prepay this expensive and restrictive term debt by year end 2021.

 

“We have completed or are on track to complete this year a number of projects that will increase our annual EBITDA by $18.5 million starting in 2022. Long-term, we will continue to build on our specialty alcohols and essential ingredients business, focusing our resources on driving profitable growth and progressing our strategic initiatives.”

 

 

 

 

 

“Net sales were $306 million, up approximately $100 million from the prior year’s quarter due to an increase in both gallons produced and the average price per gallon sold,” stated Bryon McGregor, CFO of Alto Ingredients. “Last year’s specialty alcohol sales uniquely benefited from a spike in sanitizer and disinfectant demand from COVID-19. When examining costs and bottom line comparatively, the planned outage of our wet mill, as expected, materially impacted our total revenues and cost of goods sold, driving the gross loss in this year’s quarter compared to last year’s gross profit.

 

“Going forward, while we anticipate continued volatility in sanitizer and disinfectant demand over foreseeable future, we expect a more stable, new demand-supply equilibrium will ultimately be achieved as COVID-19 impacts dissipate. We also expect an increase in fixed-price contracted specialty alcohol sales and growing specially alcohol exports. Our upgraded wet mill facility with significantly improved efficiency and reliability will enable us to further support customer demand long term.”

 

Financial Results for the Three Months Ended September 30, 2021 Compared to 2020

 

Net sales were $305.6 million, compared to $204.7 million.
   
Cost of goods sold was $309.0 million, compared to $183.8 million.  
   
Gross loss was $3.4 million, compared to a gross profit of $20.9 million.
   
Selling, general and administrative expenses were $5.5 million, compared to $6.4 million.
   
Operating loss was $8.9 million, compared to operating income of $26.3 million.
   
Net loss available to common stockholders was $3.5 million, or $0.05 per share, compared net income of $14.9 million, or $0.24 per diluted share.
   
Adjusted EBITDA was $3.0 million, compared to $34.1 million.
   
Cash and cash equivalents were $36.0 million at September 30, 2021, compared to $47.7 million at December 31, 2020. On November 8, 2021, the company announced its sale of its fuel-grade ethanol production facility in Stockton, California for $24.0 million in cash.

 

Financial Results for the Nine Months Ended September 30, 2021 Compared to 2020

 

Net sales were $822.4 million, compared to $728.2 million.
   
Cost of goods sold was $796.7 million, compared to $689.0 million.  
   
Gross profit was $25.7 million, compared to $39.2 million.
   
Selling, general and administrative expenses were $19.8 million, compared to $25.2 million.
   
Operating income was $2.8 million, compared to $25.7 million.
   
Net income available to common stockholders was $9.0 million, or $0.12 per diluted share, compared to $4.1 million, or $0.07 per diluted share.
   
Adjusted EBITDA was $33.4 million, compared to $50.6 million.

 

2

 

 

 

 

Third Quarter 2021 Results Conference Call

 

Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, November 9, 2021, and will deliver prepared remarks via webcast followed by a question-and-answer session.

 

The webcast for the call can be accessed from Alto Ingredients’ website at www.altoingredients.com. Alternatively, you may dial the following number up to ten minutes prior to the scheduled conference call time: (877) 847-6066. International callers should dial 00-1 (970) 315-0267. The pass code will be 3778898. If you are unable to participate in the live call, the webcast will be archived for replay on Alto Ingredients’ website for one year. In addition, a telephonic replay will be available at 8:00 p.m. Eastern Time on Tuesday, November 9, 2021, through 8:00 p.m. Eastern Time on Tuesday, November 16, 2021. To access the replay, please dial (855) 859-2056. International callers should dial 00-1 (404) 537-3406. The pass code will be 3778898.

 

Use of Non-GAAP Measures

 

Management believes that certain financial measures not in accordance with generally accepted accounting principles (“GAAP”) are useful measures of operations. The company defines Adjusted EBITDA as unaudited net income (loss) attributed to Alto Ingredients, Inc. before interest expense, interest income, provision (benefit) for income taxes, asset impairments, loss on extinguishment of debt, purchase accounting adjustments, fair value adjustments, and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss) attributed to Alto Ingredients, Inc. Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company’s performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) attributed to Alto Ingredients, Inc. or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool and you should not consider this measure in isolation or as a substitute for analysis of the company’s results as reported under GAAP.

 

About Alto Ingredients, Inc.

 

Alto Ingredients, Inc. (ALTO), formerly known as Pacific Ethanol, Inc., is a leading producer of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company’s customers include major food and beverage companies and consumer products companies. For more information please visit www.altoingredients.com.

 

3

 

 

 

 

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

 

Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning the timing and effects of Alto Ingredients’ strategic initiatives, including its plant improvement projects and extended certifications; the expected effect on annual EBITDA of Alto Ingredients’ plant improvement projects; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business. These factors include, among others, adverse economic and market conditions, including for specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; Alto Ingredients’ ability to successfully and timely execute on its plant improvement projects; and the effects – both positive and negative – of the coronavirus pandemic and its resurgence or abatement. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the specialty alcohol production and marketing industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ distilleries, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 10, 2021.

 

Media Contact:

Bryon McGregor, Alto Ingredients, Inc., 916-403-2768, mediarelations@altoingredients.com

 

Company IR Contact:

Michael Kramer, Alto Ingredients, Inc., 916-403-2755, Investorrelations@altoingredients.com

 

IR Agency Contact:

Moriah Shilton, LHA Investor Relations, 415-433-3777, Investorrelations@altoingredients.com

 

4

 

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited, in thousands, except per share data)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2021   2020   2021   2020 
                 
Net sales  $305,556   $204,727   $822,400   $728,205 
Cost of goods sold   308,955    183,797    796,729    688,983 
Gross profit (loss)   (3,399)   20,930    25,671    39,222 
Selling, general and administrative expenses   (5,533)   (6,404)   (19,777)   (25,245)
Asset impairments           (3,100)    
Gain on litigation settlement       11,750        11,750 
Income (loss) from operations   (8,932)   26,276    2,794    25,727 
Interest expense, net   (429)   (4,199)   (3,359)   (14,153)
Income from loan forgiveness   5,973        9,860     
Fair value adjustments       (6,856)       (7,497)
Other income (expense), net   256    (6)   641    (1,164)
Income (loss) before benefit for income taxes   (3,132)   15,215    9,936    2,913 
Benefit for income taxes                
Consolidated net income (loss)   (3,132)   15,215    9,936    2,913 
Net loss attributed to noncontrolling interests               2,166 
Net income (loss) attributed to Alto Ingredients, Inc.  $(3,132)  $15,215   $9,936   $5,079 
Preferred stock dividends  $(319)  $(319)  $(946)  $(949)
Net income (loss) available to common stockholders  $(3,451)  $14,896   $8,990   $4,130 
Net income (loss) per share, basic  $(0.05)  $0.25   $0.13   $0.07 
Net income (loss) per share, diluted  $(0.05)  $0.24   $0.12   $0.07 
Weighted-average shares outstanding, basic   71,383    58,503    71,002    55,620 
Weighted-average shares outstanding, diluted   71,383    61,699    72,260    57,958 

 

5

 

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)

 

   September 30,   December 31, 
ASSETS  2021   2020 
Current Assets:        
Cash and cash equivalents  $36,029   $47,667 
Accounts receivable, net   78,424    43,491 
Inventories   58,117    37,925 
Prepaid inventory   5,480    891 
Derivative instruments   12,977    17,149 
Assets held-for-sale   30,158    58,295 
Other current assets   5,413    8,628 
Total current assets   226,598    214,046 
Property and equipment, net   224,319    229,486 
Other Assets:          
Right of use operating lease assets, net   12,715    11,046 
Notes receivable   12,423    14,337 
Intangible assets   2,678    2,678 
Other assets   4,671    5,225 
Total other assets   32,487    33,286 
Total Assets  $483,404   $476,818 

 

6

 

 

 

 

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)

 

   September 30,   December 31, 
LIABILITIES AND STOCKHOLDERS’ EQUITY  2021   2020 
Current Liabilities:        
Accounts payable – trade  $28,387   $13,047 
Accrued liabilities   15,455    11,101 
Current portion – operating leases   3,216    2,180 
Current portion – long-term debt   17,687    25,533 
Derivative instruments   2,735     
Liabilities held-for-sale   10,500    19,542 
Other current liabilities   6,468    15,524 
Total current liabilities   84,448    86,927 
           
Long-term debt, net of current portion   70,621    71,807 
Operating leases, net of current portion   9,365    8,715 
Other liabilities   13,774    13,134 
Total Liabilities   178,208    180,583 
           
Stockholders’ Equity:          
Alto Ingredients, Inc. Stockholders’ Equity:          
Preferred stock, $0.001 par value; 10,000 shares authorized;
Series A: 0 shares issued and outstanding as of
September 30, 2021 and December 31, 2020
Series B: 927 shares issued and outstanding as of
September 30, 2021 and December 31, 2020
   1    1 
Common stock, $0.001 par value; 300,000 shares authorized; 72,800 and 72,487 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively   73    72 
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2021 and December 31, 2020        
Additional paid-in capital   1,036,608    1,036,638 
Accumulated other comprehensive loss   (3,878)   (3,878)
Accumulated deficit   (727,608)   (736,598)
Total Stockholders’ Equity   305,196    296,235 
Total Liabilities and Stockholders’ Equity  $483,404   $476,818 

 

7

 

 

 

 

Reconciliation of Adjusted EBITDA to Net Income (Loss)

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
(in thousands) (unaudited)  2021   2020   2021   2020 
Net income (loss) attributed to Alto Ingredients, Inc.  $(3,132)  $15,215   $9,936   $5,079 
Adjustments:                    
Interest expense   429    4,199    3,359    14,153 
Interest income   (183)   (196)   (553)   (368)
Asset impairments           3,100     
Fair value adjustments       6,856        7,497 
Benefit for income taxes                
Depreciation and amortization expense*   5,851    8,049    17,520    24,254 
Total adjustments   6,097    18,908    23,426    45,536 
Adjusted EBITDA  $2,965   $34,123   $33,362   $50,615 

 

 

*Adjusted for noncontrolling interests.

 

8

 

 

 

 

Commodity Price Performance

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
(unaudited)  2021   2020   2021   2020 
Fuel-grade ethanol production gallons sold (in millions)   38.3    21.9    118.6    148.0 
Specialty alcohol production gallons sold (in millions)   19.7    21.6    63.1    74.9 
Third party fuel-grade ethanol gallons sold (in millions)   67.2    76.7    180.5    213.0 
Total gallons sold (in millions)   125.2    120.2    362.2    435.9 
                    
Total gallons produced (in millions)   60.6    45.2    182.2    209.1 
Production capacity utilization   59%   40%   57%   54%
                     
Average sales price per gallon  $2.47   $1.71   $2.27   $1.60 
Average CBOT ethanol price per gallon  $2.25   $1.27   $2.08   $1.20 
                     
Corn cost – CBOT equivalent  $6.09   $3.29   $5.71   $3.49 
Average basis   0.89    0.22    0.53    0.29 
Delivered cost of corn  $6.98   $3.51   $6.24   $3.78 
                     
Total essential ingredients tons sold (in thousands)   305.6    255.5    886.5    1,177.5 
Co-product return % (1)   29.5%   50.2%   33.8%   44.6%

 

 

(1)Co-product revenue as a percentage of delivered cost of corn.

 

9

 

 

 

 

Segment Financials

 

   Three Months Ended
September 30,
   Nine Months Ended
September 30,
 
   2021   2020   2021   2020 
Net Sales                
Marketing and distribution:                
Alcohol sales, gross  $112,391   $84,001   $255,702   $212,625 
Alcohol sales, net   505    382    1,489    1,117 
Intersegment sales   2,415    1,598    7,277    7,751 
Total marketing and distribution sales   115,311    85,981    264,468    221,493 
                     
Pekin Campus production, recorded as gross:                    
Alcohol sales  $114,587   $77,075   $341,967   $255,737 
Essential ingredient sales   46,016    27,619    140,670    101,123 
Intersegment sales   293    197    920    877 
Total Pekin Campus sales   160,896    104,891    483,557    357,737 
                     
Other production, recorded as gross:                    
Alcohol sales  $25,190   $11,765   $63,311   $120,797 
Essential ingredient sales   6,867    3,885    19,261    36,806 
Intersegment sales   259    420    896    1,121 
Total Other production sales   32,316    16,070    83,468    158,724 
                     
Intersegment eliminations   (2,967)   (2,215)   (9,093)   (9,749)
Net sales as reported  $305,556   $204,727   $822,400   $728,205 
                     
Cost of goods sold:                    
Marketing and distribution  $105,902   $84,589   $245,606   $210,827 
Pekin Campus production   169,721    80,280    468,972    302,120 
Other production   35,613    20,718    87,055    181,382 
Intersegment eliminations   (2,281)   (1,790)   (4,904)   (5,346)
Cost of goods sold as reported  $308,955   $183,797   $796,729   $688,983 
                     
Gross profit (loss):                    
Marketing and distribution  $9,409   $1,392   $18,862   $10,666 
Pekin Campus production   (8,825)   24,611    14,585    55,617 
Other production   (3,297)   (4,648)   (3,587)   (22,658)
Intersegment eliminations   (686)   (425)   (4,189)   (4,403)
Gross profit (loss)  $(3,399)  $20,930   $25,671   $39,222 

 

 

 

10